Hey Bert, spoke with Kirin Smith. He said that the Effexor generic will earn lots of money for IPCI. He recommended that I watch the presentation and look at that. Even w/o Rexista he felt this company should be worth a few more shekels. Take a look at it over the weekend. I don't know if you celebrate it but Happy Purim.
Bert, you were smart!! You took it off at $4.50, thinking that the stinking daytraders were going to blow out as usual. You then went into sometjhing else that you figured could pop. Hey, at least you took your shot. I on the otherhand stayed in the pocket here only to see my gains frumped away, awaiting for the Moshiach to come (Rexista news). I like your plan of attack and maybe just maybe next time you will hit a grand slam with your sale!!
@Dr-c-why are we trending down so hard--I feel like you optomistic-any explannation??
asking about this company and clients buying 10k or more shares. Also funds have called about it too. Ignore the small daily grind and keep your eyes peeled on the long term. If they continuaaly make the right moves the compaby will grow strongly.
inquiring minds want to know!!!
Thank you for your inquiry. It is impossible for the Company to compare as the product from Purdue is not available for purchase and therefore analyze. IPCI's technology is different and potentially more robust in it's abuse deterrence if they are in fact using the same technology as used in oxycontin. This push for abuse deterrence is good overall for IPCI.
How can it be any better. The article states that it does exactly what Zohydro did in their tests and was anti-tampering. I am confused!!!